Antibiotics and Bacterial Resistance in the 21st Century
By Richard J. Fair, Y. Tor. Perspectives in Medicinal Chemistry, 2014
1,724 citations recorded by the source corpus.
Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addressed. Profiles of bacterial species that are deemed to be particularly concerning at the present time are illustrated. Factors including economic impact, intrinsic and acquired drug resistance, morbidity and mortality rates, and means of infection are taken into account. Synchronously with the waxing of bacterial resistance there has been waning antibiotic development. The approaches that scientists are employing in the pursuit of new antibacterial agents are briefly described. The standings of established antibiotic classes as well as potentially emerging classes are assessed with an emphasis on molecules that have been clinically approved or are in advanced stages of development. Historical perspectives, mechanisms of action and resistance, spectrum of activity, and preeminent members of each class are discussed.
Subfields: Applied Microbiology and Biotechnology, Clinical Biochemistry, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/b92d6fd3b3fbda0afdf87b0f381f6fa4c6cfc11b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- B. Crona
- Line J. Gordon
- Stephan Barthel
- Carl Folke
- L. Deutsch
- Victoria Bignet
- M. Troell
- P. Henriksson
Citations in the corpus
- Rewiring food systems to enhance human health and biosphere stewardship (2017, background): “These diet related diseases represent 80% of mortality in low and middle-income countries [43].”
- Antibiotic resistance: a rundown of a global crisis (2018, background): “It is therefore believed that resistance and virulence have evolved during different eras.(52) Regardless of evolutionary differences, these processes share common features, and both processes are indispensable for the survival of bacteria under adverse environments.”
- Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. (2019, background): “…the expression of these components typically resulting in ‘‘rough’’ colony-forming mutants through phase variable expression of LPS, point mutations, or even large chromosomal deletions in LPS biosynthesis genes (Seed et al., 2012; Kim and Ryu, 2011, 2012; Filippov et al., 2011; Le et al., 2014).”
- A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery (2019, background): “In addition, many secondary metabolites can affect cell signalling or protect against oxidative or UV stress [38].”
- Bacteria Antibiotic Resistance: New Challenges and Opportunities for Implant-Associated Orthopaedic Infections (2017, background): “For instance, MRSA is resistant to numerous penicillin-like b-lactam antibiotics primarily due to its expression of the mecA gene which encodes the low affinity penicillin binding protein PBP 2a.(20) The Antibiotic Resistance Genes Database currently lists the existence of more than 23,000 potential”